- Home
- DELL vs AZN Comparison
DELL vs AZN Comparison
Compare DELL & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DELL | AZN |
|---|---|---|
| Founded | 1984 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.7B | 250.7B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DELL | AZN |
|---|---|---|
| Price | $322.00 | $187.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 12 |
| Target Price | ★ $590.00 | $206.66 |
| AVG Volume (30 Days) | ★ 5.6M | 3.0M |
| Earning Date | 11-24-2026 | 10-30-2026 |
| Dividend Yield | 0.68% | ★ 1.71% |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 11.58 | N/A |
| Revenue | ★ $113,538,000,000.00 | N/A |
| Revenue This Year | $70.41 | $7.85 |
| Revenue Next Year | $19.24 | $6.36 |
| P/E Ratio | $32.06 | ★ $31.91 |
| Revenue Growth | ★ 18.80 | N/A |
| 52 Week Low | $110.22 | $84.22 |
| 52 Week High | $595.51 | $212.71 |
Technical Indicators
Market Signals| Indicator | DELL | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 31.04 | 73.83 |
| Support Level | $365.69 | $180.98 |
| Resistance Level | $463.48 | $191.50 |
| Average True Range (ATR) | 24.83 | 3.02 |
| MACD | -11.11 | 2.27 |
| Stochastic Oscillator | 3.29 | 99.22 |
Price Performance
Historical ComparisonAbout DELL Dell Technologies Inc.
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.